Roche Molecular Dx Sales Slip in H1; Unit's Chief Tapped to Replace Company CEO | GenomeWeb
NEW YORK (GenomeWeb News) — Roche said today that revenue from its Molecular Diagnostics division declined during the first six months of the year, though overall Diagnostics revenue increased.
 
Also, Applied Science receipts increased on strong sales of its LightCycler 480 and Genome Sequencer 20 and GS FLX systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.